Postmenopausal Osteoporosis Market Share

  • Report ID: 5653
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Postmenopausal Osteoporosis Market Regional Analysis:

APAC Market Insights

Postmenopausal osteoporosis market in the Asia Pacific region, amongst the market in all the other regions, is slated to hold the largest with a share of about 38% by the end of 2035. The region's growing aging population and accompanying demographic shift are likely to drive market demand. The World Health Organization (WHO) projects that by 2050, the share of older adults in Asia will rise to 28.3%.

Postmenopausal osteoporosis is more common than ever before because of the sharp rise in osteoporosis risk that comes with aging. This demographic trend emphasizes the growing incidence of osteoporosis in the senior population, underscoring the need for targeted healthcare measures.

Osteoporosis is becoming more common in the Asia Pacific region as a result of significant dietary and lifestyle changes. Rising urbanization and changing dietary preferences have resulted in a noticeable decline in traditional diets rich in calcium and other minerals that support bone health. Simultaneously, sedentary lifestyles have grown in favor of postmenopausal osteoporosis market.

North America Market Insights

The postmenopausal osteoporosis market in North America is expected to develop significantly in the upcoming years and is expected to keep the second position. This is due to the region's population's food and lifestyle choices, which have a significant impact on bone health. Adults in North America are showing a worrying trend of insufficient calcium intake, according to a study published in Osteoporosis International.

Unhealthy food choices, such as consuming less dairy and foods high in calcium, can lead to less than ideal bone health. In order to improve bone density and avoid postmenopausal osteoporosis in the North American population, it is imperative that certain lifestyle variables be addressed.

Postmenopausal Osteoporosis Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of postmenopausal osteoporosis is assessed at USD 8.25 billion.

The global postmenopausal osteoporosis market size was valued at over USD 7.9 billion in 2025 and is expected to expand at a CAGR of around 4.9%, surpassing USD 12.75 billion revenue by 2035.

Asia Pacific postmenopausal osteoporosis market will dominate more than 38% share, driven by the region’s aging population, dietary changes, and increasing incidence of osteoporosis, forecast period 2026–2035.

Key players in the market include Amgen Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., Merck & Co., Inc., Cipla Inc., Innovent Biologics, Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Private Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos